LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Portable Rapid Diagnostic Assay Identifies Hemorrhaging Patients Using Small Blood Sample

By LabMedica International staff writers
Posted on 29 Aug 2023
Image: A prototype of the portable internal hemorrhage diagnostic tool for prehospital settings (Photo courtesy of DioTeX)
Image: A prototype of the portable internal hemorrhage diagnostic tool for prehospital settings (Photo courtesy of DioTeX)

Hemorrhaging occurs when blood vessels are damaged due to a traumatic event, leading to either visible external or hidden internal bleeding. While external bleeding is easily detectable, internal bleeding, also referred to as internal hemorrhaging, remains hidden from plain sight. Diagnosing internal bleeding demands clinical suspicion and subsequent assessment. Within hospital settings, advanced imaging can confirm these assessments, enabling timely surgical intervention to save lives. However, current methods for detecting hemorrhage are insufficient and require skilled operators, presenting significant diagnostic challenges. Now, a revolutionary internal hemorrhage diagnostic tool could change all that.

DioTeX Diagnostics (Baltimore, MD, USA), comprising a team of undergraduate biomedical engineers from Johns Hopkins University (Baltimore, MD, USA), is developing a portable, dependable, and accessible internal hemorrhage diagnostic tool. Their approach involves using a specific biomarker associated with hemorrhage to create a rapid immunochemistry-based test. By analyzing a small blood sample, this tool can swiftly identify patients with internal bleeding. This test has the potential to revolutionize internal hemorrhage diagnosis, as it can be conducted accurately and consistently by individuals with minimal training. This innovation holds the promise of faster and more appropriate hemorrhage care, potentially saving thousands of lives annually.

DioTeX has built a prototype of its portable rapid diagnostic assay designed to detect blood biomarkers linked to trauma-induced hemorrhage. This advancement aims to enhance the evaluation and management of internal trauma. Using the device, critical diagnostic results can be obtained and interpreted by anyone, regardless of location. To utilize the device, a blood sample is collected from behind the ear of a patient who may be experiencing internal bleeding. This process employs DioTeX's proprietary blood drawing mechanism. After approximately 5 minutes, users can interpret the test device's reading. A single line indicates no hemorrhage, while two lines indicate the presence of bleeding. The testing device requires minimal training, making it practical for use in settings with limited resources and in rural areas.

Related Links:
DioTeX Diagnostics 
Johns Hopkins University 

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Hemodynamic System Monitor
OptoMonitor

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more